GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services
PR Newswire Asia
· Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test..
· Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test..
· Cash and cash equivalents at €11.0 million, short-term^2 deposits at €0.1million, and long-term deposit at €19.1 million^3..
GoldenPeaks Capital Holding Ltd. / Key word(s): Agreement
GoldenPeaks Capital and Reckitt have signed a 10-year Power Purchase..